Lataa...
Delayed rejection of MHC class II-disparate skin allografts in mice treated with farnesyltransferase inhibitors
Farnesyltransferase inhibitors (FTIs), developed as anti-cancer drugs, have the potential to modulate immune responses without causing nonspecific immune suppression. We have investigated the possibility that FTIs, by affecting T cell cytokine secretion, can attenuate alloreactive immune responses....
Tallennettuna:
| Julkaisussa: | Transpl Immunol |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
2008
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7369389/ https://ncbi.nlm.nih.gov/pubmed/18930822 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trim.2008.09.011 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|